Answers are grounded in this paper and cite their sources.
Highlights the discrepancy between clinical evidence supporting the efficacy of long-acting nitrates and their restrictive FDA labeling and dosage recommendations.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Jonathan Abrams (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: